POSEIDA THERAPEUTICS INC (PSTX)
US73730P1084 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 31.2M | 130.5M 318.27% | 64.703M -50.42% | 150.06M 131.92% | 44.2M -70.55% | 22.44M -49.23% | 103.83M 362.70% | 386.97M 272.70% | 822.57M 112.57% | 1.184B 43.94% | 1.503B 26.94% | |
| EBITDA YoY % growth | -136.85M -10.44% | -54.73M 60.01% | -123.89M -126.37% | -125.266M -1.11% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -141.4M -11.78% | -59.9M 57.64% | -129.504M -116.20% | -95.307M 26.41% | -216.353M -127.01% | -276.538M -27.82% | -219.467M 20.64% | 51.248M 123.35% | 380.52M 642.51% | 633.64M 66.52% | 852.9M 34.60% | |
| Operating Margin | -453.21% | -45.90% | -200.15% | -63.51% | -489.49% | -1,232.35% | -211.37% | 13.24% | 46.26% | 53.52% | 56.75% | |
| EPS YoY % growth | -2.02 36.12% | -1.09 46.04% | -1.39 -27.52% | -0.97 30.29% | -1.72 -77.11% | -1.41 17.78% | -1.19 15.42% | 0.23 119.66% | 1.68 617.39% | 2.79 66.06% | 3.08 10.22% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.37 -36.00% | -0.48 -90.40% | -0.52 -61.50% | -0.48 -326.67% | -0.39 -5.56% | -0.22 52.86% | -0.22 56.58% | -0.23 50.71% | -0.23 39.47% |
| Revenue Q2Q % growth | 17.34M -30.63% | 7.65M -72.82% | 7.65M -70.55% | 7.65M -89.34% | 7.65M -55.88% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -37.738M -45.65% | -42.84M -74.31% | -48.45M -52.57% | -48.45M -345.42% | -54.06M -43.25% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.21 160.00% | -0.42 | 0.63 | 150.52% |
| Q2 2024 Q2Q % growth | -0.32 | -0.42 | 0.10 | 23.01% |
| Q1 2024 Q2Q % growth | -0.25 44.44% | -0.43 | 0.18 | 41.64% |
| Q4 2023 Q2Q % growth | -0.27 30.77% | -0.39 | 0.12 | 31.42% |
| Q3 2023 Q2Q % growth | -0.35 -138.04% | -0.30 | -0.05 | -17.31% |
| Q2 2023 Q2Q % growth | -0.32 53.62% | -0.54 | 0.22 | 40.58% |
| Q1 2023 Q2Q % growth | -0.45 51.61% | -0.46 | 0.01 | 1.96% |
| Q4 2022 Q2Q % growth | -0.39 -2,050.00% | -0.23 | -0.16 | -69.93% |
| Q3 2022 Q2Q % growth | 0.92 235.29% | -0.67 | 1.59 | 238.23% |
| Q2 2022 Q2Q % growth | -0.69 6.76% | -0.78 | 0.09 | 11.57% |
| Q1 2022 Q2Q % growth | -0.93 -50.00% | -0.68 | -0.25 | -37.11% |
| Q4 2021 Q2Q % growth | 0.02 103.45% | -0.35 | 0.37 | 105.64% |
| Q3 2021 Q2Q % growth | -0.68 -7.94% | -0.76 | 0.08 | 10.31% |
| Q2 2021 Q2Q % growth | -0.74 67.54% | -0.64 | -0.10 | -15.16% |
| Q1 2021 Q2Q % growth | -0.62 | -0.65 | 0.03 | 4.28% |
| Q4 2020 Q2Q % growth | -0.58 | -0.70 | 0.12 | 17.19% |
| Q3 2020 Q2Q % growth | -0.63 | -0.56 | -0.07 | -12.30% |
| Q2 2020 Q2Q % growth | -2.28 | -1.51 | -0.77 | -51.03% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 71.748M 667.19% | 16.592M | 55.156M | 332.43% |
| Q2 2024 Q2Q % growth | 25.973M 29.78% | 15.742M | 10.231M | 64.99% |
| Q1 2024 Q2Q % growth | 28.142M 172.09% | 11.9M | 16.242M | 136.49% |
| Q4 2023 Q2Q % growth | 24.995M 147.48% | 6.783M | 18.212M | 268.49% |
| Q3 2023 Q2Q % growth | 9.352M -91.96% | 14.433M | -5.081M | -35.20% |
| Q2 2023 Q2Q % growth | 20.013M 641.22% | 5.177M | 14.836M | 286.58% |
| Q1 2023 Q2Q % growth | 10.343M 638.79% | 9.563M | 780K | 8.16% |
| Q4 2022 Q2Q % growth | 10.1M -67.63% | 62.921M | -52.821M | -83.95% |
| Q3 2022 Q2Q % growth | 116.3M | 1.003M | 115.297M | 11,495.21% |
| Q2 2022 Q2Q % growth | 2.7M | 1.08M | 1.62M | 150.00% |
| Q1 2022 Q2Q % growth | 1.4M | 637.5K | 762.5K | 119.61% |
| Q4 2021 Q2Q % growth | 31.2M | 16.15M | 15.05M | 93.19% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 8.28% | -34.28% | 32.74% |
| Revenue | 0% | 10.15% | 0% | 69.87% |